Although U0126 showed a trend to reduce enhancement of p-ERK by ELZC, we did not see a significant drop in the group of ELZC in combination with U0126, compared to the ELZC group ( Figure 7C ).
← all excerpts
Prediction of the Molecular Mechanisms Underlying Erlong Zuoci Treatment of Age-Related Hearing Loss via Network Pharmacology-Based Analyses Combined with Experimental Validation.
1
—
—